Effect of pentoxifylline on preventing acute kidney injury after cardiac surgery by measuring urinary neutrophil gelatinase - associated lipocalin
2011

Pentoxifylline and Kidney Injury After Heart Surgery

Sample size: 28 publication 10 minutes Evidence: moderate

Author Information

Author(s): Barkhordari Khosro, Karimi Abbasali, Shafiee Akbar, Soltaninia Hasan, Khatami Mohammad Reza, Abbasi Kiomars, Yousefshahi Fardin, Haghighat Babak, Brown Virginia

Primary Institution: Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran

Hypothesis

Does pentoxifylline prevent acute kidney injury after cardiac surgery?

Conclusion

Pentoxifylline may reduce the rise of creatinine levels after cardiac surgery, suggesting a potential benefit in preventing acute kidney injury.

Supporting Evidence

  • Pentoxifylline was administered to patients undergoing cardiac surgery to assess its effect on kidney injury.
  • The study found no significant difference in urinary neutrophil gelatinase-associated lipocalin levels between the treatment and control groups.
  • Significant differences in serum creatinine levels were observed at 24 and 48 hours post-surgery.

Takeaway

This study looked at whether a medicine called pentoxifylline can help protect the kidneys during heart surgery. It found that while it might help a little, more research is needed.

Methodology

A double-blind randomized clinical trial with 28 patients undergoing elective coronary artery bypass graft surgery, comparing pentoxifylline to placebo.

Limitations

The small sample size limits the power to detect significant differences.

Participant Demographics

Patients undergoing elective coronary artery bypass graft surgery, with a mean age of approximately 58 years.

Statistical Information

P-Value

0.02; 0.03

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1749-8090-6-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication